These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials. Chen D; Yang D; Dougherty CA; Lu W; Wu H; He X; Cai T; Van Dort ME; Ross BD; Hong H ACS Nano; 2017 Apr; 11(4):4315-4327. PubMed ID: 28345871 [TBL] [Abstract][Full Text] [Related]
5. Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery. Abánades Lázaro I; Wells CJR; Forgan RS Angew Chem Int Ed Engl; 2020 Mar; 59(13):5211-5217. PubMed ID: 31950568 [TBL] [Abstract][Full Text] [Related]
6. Evaluating UiO-66 Metal-Organic Framework Nanoparticles as Acid-Sensitive Carriers for Pulmonary Drug Delivery Applications. Jarai BM; Stillman Z; Attia L; Decker GE; Bloch ED; Fromen CA ACS Appl Mater Interfaces; 2020 Sep; 12(35):38989-39004. PubMed ID: 32805901 [TBL] [Abstract][Full Text] [Related]
7. Folic Acid Functionalized Zirconium-Based Metal-Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Delivery. Dong H; Yang GX; Zhang X; Meng XB; Sheng JL; Sun XJ; Feng YJ; Zhang FM Chemistry; 2018 Nov; 24(64):17148-17154. PubMed ID: 30125400 [TBL] [Abstract][Full Text] [Related]
8. PEGylated Nanoscale Metal-Organic Frameworks for Targeted Cancer Imaging and Drug Delivery. Zeng Y; Xiao J; Cong Y; Liu J; He Y; Ross BD; Xu H; Yin Y; Hong H; Xu W Bioconjug Chem; 2021 Oct; 32(10):2195-2204. PubMed ID: 34591471 [TBL] [Abstract][Full Text] [Related]
9. Endocytosis Mechanism of Nano Metal-Organic Frameworks for Drug Delivery. Orellana-Tavra C; Mercado SA; Fairen-Jimenez D Adv Healthc Mater; 2016 Sep; 5(17):2261-70. PubMed ID: 27385477 [TBL] [Abstract][Full Text] [Related]
10. A fluorometric assay for rapid enrichment and determination of bacteria by using zirconium-metal organic frameworks as both capture surface and signal amplification tag. Yang S; Guo Y; Fan J; Yang Y; Zuo C; Bai S; Sheng S; Li J; Xie G Mikrochim Acta; 2020 Feb; 187(3):188. PubMed ID: 32095939 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of defective UiO-66 for efficient co-immobilization of arsenate and fluoride from single/binary solutions. Prabhu SM; Chuaicham C; Park CM; Jeon BH; Sasaki K Environ Pollut; 2021 Jun; 278():116841. PubMed ID: 33735792 [TBL] [Abstract][Full Text] [Related]
12. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer. Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060 [TBL] [Abstract][Full Text] [Related]
13. Customizable Zr-MOF nanoantidote-based multieffective arsenic detoxification and its extended low-toxic therapy. Zhong Y; Zhang W; Xiao H; Kong Y; Huang W; Bai D; Yu S; Gao J; Wang X Acta Biomater; 2024 Jul; 182():228-244. PubMed ID: 38761962 [TBL] [Abstract][Full Text] [Related]
14. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery. Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422 [TBL] [Abstract][Full Text] [Related]
15. One-pot doping platinum porphyrin recognition centers in Zr-based MOFs for ratiometric luminescent monitoring of nitric oxide in living cells. Ye Y; Liu H; Li Y; Zhuang Q; Liu P; Gu J Talanta; 2019 Aug; 200():472-479. PubMed ID: 31036211 [TBL] [Abstract][Full Text] [Related]
16. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy. Wu MX; Yang YW Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370555 [TBL] [Abstract][Full Text] [Related]
17. Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Delivery. Abánades Lázaro I; Haddad S; Sacca S; Orellana-Tavra C; Fairen-Jimenez D; Forgan RS Chem; 2017 Apr; 2(4):561-578. PubMed ID: 28516168 [TBL] [Abstract][Full Text] [Related]
19. Biocompatible, Crystalline, and Amorphous Bismuth-Based Metal-Organic Frameworks for Drug Delivery. Orellana-Tavra C; Köppen M; Li A; Stock N; Fairen-Jimenez D ACS Appl Mater Interfaces; 2020 Feb; 12(5):5633-5641. PubMed ID: 31940165 [TBL] [Abstract][Full Text] [Related]
20. Thermal Stimuli-Triggered Drug Release from a Biocompatible Porous Metal-Organic Framework. Jiang K; Zhang L; Hu Q; Zhang Q; Lin W; Cui Y; Yang Y; Qian G Chemistry; 2017 Jul; 23(42):10215-10221. PubMed ID: 28682004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]